• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

NZ-Based Healthcare Messaging Platform Celo Health Launches in the US

Share:

January 18, 2022

Celo Health, an Auckland-based provider of a mobile messaging platform for healthcare organizations, has entered the United States market. It has set up headquarters in Seattle early in the year.

WHAT IT DOES

According to a press release, Celo Health offers a HIPAA-compliant messaging platform that enables seamless and secure collaboration among healthcare teams. It can also integrate with hospitals’ existing electronic health records.

Available on iOS, Android, and web devices, the app has the On-Call feature which allows teams to instantly reach the right on-call provider and a reporting dashboard where insights can be drawn for improvements, such as resource allocation and process enhancements.

One competitive feature of the app is rostering optimization which allows users to send role-based messages instead of looking up a name of a provider from a directory. Another feature is Broadcast which enables administrative users to send out mass messages, as well as see the reach of those messages.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The press statement also went on to mention that the Celo Health platform optimizes clinical workflows, helps increase worker productivity, and minimizes risks of data breaches and fines by ensuring compliance.

WHY IT MATTERS

In an interview with MobiHealth News, Jack Clough, chief growth officer at Celo Health who is now leading its US office, shared how the company will be able to set its platform apart from local competition.

He noted how generic enterprise messaging products in the market mostly lack healthcare-specific features. “Those generic messaging products put patients’ data at risk which exposes healthcare providers to fines and legal risks,” Clough emphasized.

Designed by a medical doctor, Celo Health’s mobile app is specifically built for the healthcare industry. Clough claimed that they have proven success in countries with stricter security compliance requirements, such as the UK, Australia, and New Zealand, where they currently have around 800 partner healthcare organizations. In the UK, for instance, one client organization reported about an 80% adoption rate of its messaging platform among staff.

Celo Health is currently in advanced talks with a Tier 1 hospital in Seattle for potential signing; Clough also mentioned that they are eyeing half a dozen more prospects in the state.

THE LARGER TREND

In October, Melbourne-based IT firm FiveP unveiled a role-based messaging app called Baret that offers EMR/PAS integration. It was initially developed to support internal communications at Austin Health and was further tweaked to demonstrate how role-based communications could be done on Microsoft Teams.

Singaporean private healthcare group Thomson Medical tapped Chicago-based messaging solutions company NetSfere in 2020 to roll out the latter’s enterprise-grade secure messaging platform for internal communication and collaboration.

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • California Physician Practices to Use Apple Watches to Advance Physician-Patient CommunicationCalifornia Physician Practices to Use Apple Watches to Advance Physician-Patient Communication
  • athenahealth Enters Definitive Agreement to be Acquired by Veritas Capital For $135 Per Share in Cashathenahealth Enters Definitive Agreement to be Acquired by Veritas Capital For $135 Per Share in Cash
  • Aidoc gets third FDA nod for AI-based cervical spine fracture algorithmAidoc gets third FDA nod for AI-based cervical spine fracture algorithm
  • Tahoe Fracture and Spine Nevada Merge to Create the Largest Musculoskeletal Care Platform in the State of NevadaTahoe Fracture and Spine Nevada Merge to Create the Largest Musculoskeletal Care Platform in the State of Nevada
  • Global Asthma Drugs Market 2020 Covid-19 Impact and Recovery AnalysisGlobal Asthma Drugs Market 2020 Covid-19 Impact and Recovery Analysis
  • Pioneer in Healthcare Training Acquires Med Tech InstitutePioneer in Healthcare Training Acquires Med Tech Institute
  • UPenn Medical School Develops Low Cost COVID-19 Test Called RapidUPenn Medical School Develops Low Cost COVID-19 Test Called Rapid
  • GRAIL, Carrum Health Partners to Help Employers Address Cancer CareGRAIL, Carrum Health Partners to Help Employers Address Cancer Care

Trending This Week

  • Immuno-Oncology Pipeline Cuts Explained
  • Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
  • USFDA Accepts Glenmark’s Application to Initiate a Human Trial of Molecules for Advanced Solid Tumors and Lymphomas
  • Concentra’s Buy Offer May Jeopardize Jounce’s Merger with Redx
  • Pfizer Acquires Seagen For $43B To Tackle Cancer
  • Janssen’s Novel Dengue Antiviral Demonstrates ‘strong Protection’ in Pre-Clinical Data

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications